Smith, C P S <br/><br/>
Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates.  [electronic resource] 

 -  Neuropharmacology  Feb 2007 
 - 515-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2006.08.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Disease Models, Animal<br/>Drug Administration Schedule<br/>Drug Interactions<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Haplorhini<br/>Levodopa--adverse effects<br/>Male<br/>Models, Biological<br/>Nerve Tissue Proteins--metabolism<br/>Oxidopamine<br/>Parkinson Disease, Secondary--chemically induced<br/>Protein Kinase C--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Selective Estrogen Receptor Modulators--therapeutic use<br/>Tamoxifen--therapeutic use<br/>Time Factors